Overview


According to FutureWise analysis the market for Emphysema Treatment in 2023 is US$ 4.66 billion, and is expected to reach US$ 7.38 billion by 2031 at a CAGR of 5.92%.

Emphysema, also known as chronic obstructive pulmonary disease (COPD), is a lung condition that causes shortness of breath due to the damage caused to lungs' air sacs (alveoli). An emphysema patient suffers from the disease for a long time. As a result of this disease, air sacs in lungs gradually become damaged, resulting in shortness of breath. It is most commonly caused by smoking that people develop emphysema. The damaged air sacs in the lungs cause inflammation and irritation, resulting in difficulty breathing. Those over the age of 40 are most likely to suffer from emphysema. The lung tissue is attacked by emphysema and breaks down over time. The respiratory system is prone to infections in patients with emphysema. In the lungs, small air sacs called alveoli are stretched and crack, causing the alveoli to disintegrate, damage, and lose their elasticity. The damaged alveoli in the lungs may become empty over time as the inner lining weakens and air becomes trapped inside. It worsens over time, resulting in loss of oxygen absorption and carbon dioxide exhalation, which makes breathing difficult. Patients with COPD are likely to suffer from emphysema as well as chronic bronchitis. As a result of emphysema, people experience shortness of breath, which damages the alveoli in their lungs. Over time, the condition causes the inner walls of air sacs to burst. Consequently, the amount of oxygen entering the bloodstream declines as a result of the decrease in lung surface area. Athma is also known as obstructive disorder due to a slowdown or even a complete cessation in inhalation and exhalation due to a large amount of inflammation of the alveoli. According to the National Emphysema Foundation, emphysema occurs when the lungs' wall is injured between air sacs. When air sacs are damaged by emphysema, their shape can change or they can be destroyed. Because the lungs are not exchanging enough gas, breathing becomes difficult. In the air sacs, there is a thin membrane lining that is damaged beyond repair, which reduces oxygen flow to the blood. Insufficient space allows air to enter the sacs because air is trapped inside alveoli due to their damage. Respiratory failure, lung infection, and heart attacks are more likely to cause death in people with emphysema. By improving shortness of breath and reducing hospitalizations, emphysema patients can be treated. A pulmonary function test is performed before treatment to determine how much air the patient can blow.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Emphysema Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Emphysema Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • GlaxoSmithKline Plc
  • Boehringer ingelheim International GmbH
  • 3M
  • Novartis AG
  • AstraZeneca
  • Merck & Co., Inc
  • Intersect ENT
  • Apotex Inc
  • Amneal Pharmaceutical LLC
  • Teva Pharmaceuticals Industries Ltd
  • Mylan N.V.
  • OptiNose US Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Centriacinar
  • Panacinar
  • Paraseptal
  • Others

By Diagnosis

  • Imaging Test
  • Lab Test
  • Spirometry
  • Others

By Treatment

  • Medication
  • Therapy
  • Surgery
  • Others

By Route of Administration

  • Oral
  • Parental
  • Inhalation
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Emphysema Treatment Market By Type, By Diagnosis, By Treatment, By Route of Administration, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Emphysema Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Emphysema Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Emphysema Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Emphysema Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Centriacinar
        2. Panacinar
        3. Paraseptal
        4. Others

  • 8.   Emphysema Treatment Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Imaging Test
        2. Lab Test
        3. Spirometry
        4. Others

  • 9.   Emphysema Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medication
        2. Therapy
        3. Surgery
        4. Others

  • 10.   Emphysema Treatment Market, By Route of Administrations Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Parental
        3. Inhalation
        4. Others

  • 11.   Emphysema Treatment Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Others

  • 12.   North America Emphysema Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Emphysema Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Emphysema Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Emphysema Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Emphysema Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Glaxo Smith Kline Plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boehringer ingelheim International GmbH
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. 3M
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novartis AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. AstraZeneca
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Merck & Co., Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Intersect ENT
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Apotex Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Amneal Pharmaceutical LLC
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Teva Pharmaceuticals Industries Ltd
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Mylan N.V.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. OptiNose US Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients